Forendo Pharma Ltd   Report issue

For profit Phase 1
Founded: Turku Finland (2013)
Status: Acquired by Organon (2021) → now Merck (2009)

Organization Overview

First Clinical Trial
2018
NCT03709420
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Forendo Pharma Ltd

Active Ingredients

Drugs in Phase 1 Trials (1)

for-6219 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Endometriosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1